ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,182Medicare Part D Prescriptions Filled, Including Refills

Rank: 237 out of 2343

$713K Total Retail Price of All Prescriptions

Rank: 313 out of 2343

785 Patients Receiving at Least One Drug in Part D
95%Patients 65 Years and Older
7% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Pennsylvania
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 785 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

4% of this provider’s 785 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

1% of this provider’s 13,865 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$50 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

18 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Pennsylvania
SIMVASTATIN 761 742 1 1
LEVOTHYROXINE SODIUM 649 637 2 2
LISINOPRIL 555 550 3 3
AMLODIPINE BESYLATE 524 500 4 5
FUROSEMIDE 392 380 5 6
METOPROLOL SUCCINATE 332 326 6 14
ATORVASTATIN CALCIUM 320 319 7 10
OMEPRAZOLE 320 299 7 4
METOPROLOL TARTRATE 303 300 9 7
HYDROCHLOROTHIAZIDE 279 279 10 11
PRAVASTATIN SODIUM 243 219 11 15
SERTRALINE HCL 241 241 12 20
MIRTAZAPINE 241 229 12 41
METFORMIN HCL 233 222 14 9
WARFARIN SODIUM 232 232 15 8
ZOLPIDEM TARTRATE 232 217 15 24
DONEPEZIL HCL 231 231 17 21
TRAMADOL HCL 211 209 18 25
ATENOLOL 189 189 19 12
ISOSORBIDE MONONITRATE ER 158 158 20 32
PANTOPRAZOLE SODIUM 146 140 21 22
DIOVAN 136 133 22 23
LOSARTAN-HYDROCHLOROTHIAZIDE 121 121 23 64
SYNTHROID 117 113 24 40
CITALOPRAM HBR 113 105 25 17
LISINOPRIL-HYDROCHLOROTHIAZIDE 109 106 26 42
LOSARTAN POTASSIUM 109 97 26 19
DIGOXIN 107 107 28 35
GLIMEPIRIDE 103 103 29 45
CARVEDILOL 102 102 30 27
PREDNISONE 100 88 31 37
TAMSULOSIN HCL 95 95 32 29
OXYBUTYNIN CHLORIDE ER 89 89 33 149
HYDROCODONE-ACETAMINOPHEN 88 85 S3 34 13
MELOXICAM 85 85 35 68
KLOR-CON M20 85 85 35 44
DIOVAN HCT 84 84 37 63
LOVASTATIN 82 82 38 47
NEXIUM 81 81 39 33
CLOPIDOGREL 81 80 39 26
LIPITOR 77 77 41 78
ALLOPURINOL 76 76 42 31
ESCITALOPRAM OXALATE 75 75 43 55
NAMENDA 75 75 43 36
PLAVIX 72 71 45 38
POTASSIUM CHLORIDE 72 69 45 18
CRESTOR 72 72 45 30
OXYCODONE-ACETAMINOPHEN 69 67 S2 48 49
TRAZODONE HCL 69 62 48 53
FLUTICASONE PROPIONATE 68 64 50 46
JANUVIA 67 64 51 50
ENALAPRIL MALEATE 66 66 52 58
POLYETHYLENE GLYCOL 3350 64 64 53 54
TOPROL XL 61 61 54 426
LATANOPROST 60 60 55 200
GABAPENTIN 60 60 55 16
PAROXETINE HCL 57 57 57 66
RISPERIDONE 56 56 58 61
LIDODERM 53 53 59 130
AZITHROMYCIN 52 50 60 39
ALENDRONATE SODIUM 51 51 61 28
DILTIAZEM 24HR ER 51 51 61 76
ZETIA 51 51 61 52
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 15, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.